<code id='45571572FB'></code><style id='45571572FB'></style>
    • <acronym id='45571572FB'></acronym>
      <center id='45571572FB'><center id='45571572FB'><tfoot id='45571572FB'></tfoot></center><abbr id='45571572FB'><dir id='45571572FB'><tfoot id='45571572FB'></tfoot><noframes id='45571572FB'>

    • <optgroup id='45571572FB'><strike id='45571572FB'><sup id='45571572FB'></sup></strike><code id='45571572FB'></code></optgroup>
        1. <b id='45571572FB'><label id='45571572FB'><select id='45571572FB'><dt id='45571572FB'><span id='45571572FB'></span></dt></select></label></b><u id='45571572FB'></u>
          <i id='45571572FB'><strike id='45571572FB'><tt id='45571572FB'><pre id='45571572FB'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:comprehensive    Page View:1765
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In